Following antigen activation, CD8+ T cells unleash a plethora of effector molecules, including cytokines (e.g., IFN-γ and TNFα) and cytotoxic agents inducing cell death (e.g., granzymes and FasL), which are integral to the process of tumor rejection (22, 37–39). This evidence concerns the gene FASLG and neoplasm.